Rankings
▼
Calendar
AKBA Q4 2016 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AKBA
Akebia Therapeutics, Inc.
$366M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
-$32M
-2078.2% margin
Operating Income
-$38M
-2478.4% margin
Net Income
-$38M
-2466.6% margin
EPS (Diluted)
$-0.98
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
$96M
Free Cash Flow
$96M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$300M
Total Liabilities
$232M
Stockholders' Equity
$68M
Cash & Equivalents
$187M
← FY 2016
All Quarters
Q1 2017 →
